Percutaneous peripheral nerve stimulation (PNS) has the potential to shift the pain management paradigm by providing an effective, no-destructive, motor-sparing neuromodulation treatment to patients earlier on the care continuum than previously considered.
Why this matters
Lumbar radiofrequency ablation (RFA) is commonly used for the management of chronic back pain. However, the pain typically returns and the procedure involves destruction of the medial branch nerves. Repeated procedures typically have diminishing returns, leading to opioid use, surgery, or implantation of permanent neuromodulation systems.
Percutaneous PNS provides a minimally invasive, non-opioid treatment option for chronic pain treatment, which could be used earlier in the care continuum than traditional neuromodulation systems.